Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/1999
10/14/1999WO1999051986A1 Methods and reagents for targeting organic compounds to selected cellular locations
10/14/1999WO1999051985A1 Diagnostic modified-nucleoside detection assay
10/14/1999WO1999051984A1 Interactions between substances and surfaces that are made up of amphiphilic molecules
10/14/1999WO1999051983A1 Method of identifying agents that block muscle atrophy
10/14/1999WO1999051982A2 Method for automated erythocytic blood group determination
10/14/1999WO1999051980A2 Rapid characterization of polymers
10/14/1999WO1999051976A1 Gas sensor which functions according to the principle of measurement of work function
10/14/1999WO1999051966A1 Devices and methods for testing tack uniformity of a coating on a substrate
10/14/1999WO1999051963A1 Method and equipment for the detection and analysis of the quantity, etc. of particles in a liquid
10/14/1999WO1999051811A2 Water weight sensor array imbedded in a sheetmaking machine roll
10/14/1999WO1999051781A1 Hepatitis c virus ns5b compositions and methods of use thereof
10/14/1999WO1999051780A1 Targeting of specific cell types for removal by the immune system
10/14/1999WO1999051778A1 Electrochemical sensor using intercalative, redox-active moieties
10/14/1999WO1999051777A2 Directed evolution biosensors
10/14/1999WO1999051773A1 Addressable protein arrays
10/14/1999WO1999051766A1 Methods for producing libraries of expressible gene sequences
10/14/1999WO1999051764A1 Method for detection of bacillus cereus emetic toxin and a kit therefor
10/14/1999WO1999051763A1 Corneal organ culture system for chemical toxicity tests of consumer products
10/14/1999WO1999051762A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
10/14/1999WO1999051744A2 A interleukin-1 receptor antagonist and uses thereof
10/14/1999WO1999051742A2 Dadd, death activator death domain protein
10/14/1999WO1999051741A2 Lyst protein complexes and lyst interacting proteins
10/14/1999WO1999051739A1 Protein variant of the net1 locus
10/14/1999WO1999051730A2 Mammalian gene encoding tolloid-like protein
10/14/1999WO1999051727A2 Human nucleic acid sequences of normal ovary tissue
10/14/1999WO1999051725A2 Assay for the diagnosis of schizophrenia based on a new peptide
10/14/1999WO1999051702A1 Luminescent compounds
10/14/1999WO1999051642A1 Antibody variants and fragments thereof
10/14/1999WO1999051635A1 Transcription factors and their use
10/14/1999WO1999051621A2 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
10/14/1999WO1999051366A1 Method for producing soil, soil-treating unit, method for treating and unit for treating
10/14/1999WO1999051284A2 Non-covalent bioconjugates useful for diagnosis and therapy
10/14/1999WO1999051265A1 Nucleic acid encoding hyaluronan synthase and methods of use
10/14/1999WO1999051186A2 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
10/14/1999WO1999045354A3 Luminescent microbe assay
10/14/1999WO1999043809A3 Protease-activated receptor 4 and uses thereof
10/14/1999WO1999042076A3 Compounds and methods for immunotherapy and diagnosis of tuberculosis
10/14/1999WO1999038958A9 SUBSTRATE ANALOGS FOR MurG, METHODS OF MAKING SAME AND ASSAYS USING SAME
10/14/1999WO1999038013A3 Method for simultaneous identification of proteins and bonding partners
10/14/1999WO1999037814A9 Microparticles with multiple fluorescent signals
10/14/1999WO1999037783A9 Live vaccine against brucellosis
10/14/1999WO1999036544A3 Neisseria meningitidis antigens
10/14/1999WO1999036094A9 Composition and method for treating metastatic tumors or cancer induced by cells expressing sv40 tumor antigen
10/14/1999WO1999000655A3 Rapid flow-through binding assay apparatus and method
10/14/1999DE19817517A1 New benzylguanidine derivatives useful for diagnosis or therapy, especially of neuroblastoma
10/14/1999DE19815943A1 Verfahren zur erythrozytenseitigen Blutgruppen-Bestimmung A method for erythrocyte side blood group determination
10/14/1999DE19815684A1 Verfahren zur Herstellung von analytischen Hilfsmitteln A process for producing analytical aids
10/14/1999DE19815659A1 New fluorescent dyes, used for covalent fluorescent labeling of biomolecules, e.g. proteins or nucleic acids, or drugs
10/14/1999DE19815331A1 Transkriptionsfaktoren und deren Verwendung Transcription factors and their use
10/14/1999DE19814857A1 Gassensor nach dem Prinzip der Austrittsarbeitsmessung The gas sensor according to the principle of exit work measurement
10/14/1999DE19814775A1 Verfahren zur Bestimmung der Bindungskonstanten gelöster Stoffe und Substanzen an Oberflächen aus amphiphilen Molekülen A method for determining the binding constant of dissolved materials and substances of amphiphilic molecules to surfaces
10/14/1999DE19810721A1 Anwendung der 14-3-3 Proteine sowie Verfahren zur schnellen Bestimmung der 14-3-3 Proteine als sensitive Biomarker für Pollution ua mit polychlorierten Biphenylen (PCBs) und (Xeno)Östrogenen Application of 14-3-3 proteins as well as methods for rapidly determining the 14-3-3 proteins as sensitive biomarkers for Pollution example, polychlorinated biphenyls (PCBs) and (Xeno) estrogens
10/14/1999CA2740948A1 Antibody variants and fragments thereof
10/14/1999CA2329135A1 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
10/14/1999CA2328079A1 Method to detect biologically active, allergen-specific immunoglobulins
10/14/1999CA2327652A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
10/14/1999CA2327400A1 Directed evolution biosensors
10/14/1999CA2326650A1 Azo and diaza dericatives and uses thereof in phototherapy
10/14/1999CA2326066A1 A interleukin-1 receptor antagonist and uses thereof
10/14/1999CA2325562A1 Lyst protein complexes and lyst interacting proteins
10/14/1999CA2325339A1 Dadd, death activator death domain protein
10/14/1999CA2325016A1 Hepatitis c virus ns5b compositions and methods of use thereof
10/14/1999CA2324867A1 Bradykinin b1 receptor as marker for inflammatory diseases
10/14/1999CA2324656A1 Protein variant of the net1 locus
10/14/1999CA2324514A1 Methods for producing libraries of expressible gene sequences
10/14/1999CA2324510A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
10/14/1999CA2323638A1 Addressable protein arrays
10/13/1999EP0949509A1 A method of measurement of human growth hormone
10/13/1999EP0949508A1 Method, antigen complex and kit for diagnosing Lyme borreliosis
10/13/1999EP0949507A1 Agent for treating urine specimen
10/13/1999EP0949506A2 Method and apparatus for data management authentication in a clinical analyzer
10/13/1999EP0949503A1 Procedure for the detection of an analyte in a sample by measurement of electrochemiluminescence
10/13/1999EP0949498A2 Apparatus and method for differentiating erythrocytes in urine
10/13/1999EP0949336A1 Process for identification of organic material
10/13/1999EP0949334A1 Novel serine protease
10/13/1999EP0949269A1 Biosensor protein
10/13/1999EP0949002A2 Method for manufacturing analytical elements
10/13/1999EP0948746A1 Membrane and methods of preparing and using same
10/13/1999EP0948744A1 Micro system for biological analyses and method for making same
10/13/1999EP0948740A1 New method
10/13/1999EP0948647A1 Method for determining the prognosis of a patient with a neurological disease
10/13/1999EP0948646A1 Methods for identifying genes essential to the growth of an organism
10/13/1999EP0948641A1 Assay and kit for determining the condition of cells
10/13/1999EP0948639A1 Identification of blast cells in a leukocyte cell preparation
10/13/1999EP0948632A1 Methods for the characterization and selection of rna target motifs that bind compounds of pharmaceutical use
10/13/1999EP0948630A2 Cloning and characterization of napsin, an aspartic protease
10/13/1999EP0948623A2 Isolated mammalian monocyte cell genes; related reagents
10/13/1999EP0948622A1 Human mage-like protein
10/13/1999EP0948621A1 Junctional adhesion molecule (jam), a transmembrane protein of tight junctions
10/13/1999EP0948617A1 A NOVEL CLONED GABA-RECEPTOR SUBUNIT cDNA SEQUENCE AND STABLY CO-TRANSFECTED CELL LINES
10/13/1999EP0948613A1 Production of polyketides in bacteria and yeast
10/13/1999EP0948609A2 Llg polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies
10/13/1999EP0948604A2 Pyk2 related products and methods
10/13/1999EP0948595A1 MUTANT $i(OB) RECEPTORS AND NUCLEOTIDES ENCODING THEM
10/13/1999EP0948545A1 Antibodies specifically recognising a nitrosylated protein, method of preparation, therapeutic and diagnostic use
10/13/1999EP0948542A1 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
10/13/1999EP0948537A2 Protein binding fragments of gravin
10/13/1999EP0948532A1 Mouse galanin receptor galr2 and nucleotides encoding same
10/13/1999EP0948531A1 Secreted human proteins
10/13/1999EP0948530A2 Mammalian cell surface antigens; related reagents
1 ... 3181 3182 3183 3184 3185 3186 3187 3188 3189 3190 3191 3192 3193 3194 3195 3196 3197 3198 3199 3200 3201 ... 3937